The antipsychotic potential of subtype-selective 5-HT receptor ligands based on interactions with mesolimbic dopamine systems

Behavioural Brain Research

Volumn 73, Issue 1-2, 1995, Pages 15-17

  Tricklebank, M D ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

5 HT; Clozapine; Dopamine; Mesolimbic; Receptor subtype; Schizophrenia

Indexed keywords

CLOZAPINE; DOPAMINE RECEPTOR; NEUROLEPTIC AGENT; RECEPTOR SUBTYPE; SEROTONIN RECEPTOR;

ANIMAL TISSUE; CONFERENCE PAPER; DOPAMINERGIC SYSTEM; HUMAN; HUMAN TISSUE; LIMBIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; RODENT;

ANIMALS; ANTIPSYCHOTIC AGENTS; DOPAMINE; HUMANS; LIGANDS; LIMBIC SYSTEM; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN;

EID: 13344278719     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-4328(96)00064-2     Document Type: Article

References (25)

1. Molecular biology of 5-HT receptors
2. Antipsychotic drug effects on the electrical activity of dopaminergic neurons
3. 3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain
4. BMY 14802, a sigma receptor ligand for the treatment of schizophrenia
5. 4 Receptors in terminal regions of the mesolimbic system
6. 2B receptor
7. Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature
8. Ondansetron a double blind placebo controlled study in acute schizophrenia
9. Survey of the pharmacodynamics of the new antipsychotic risperidone
10. Studies of ondarsetron in schizophrenia
11. i values
12. The behavioural pharmacology of LY170053, a novel ‘atypical’ antipsychotic agent
13. 2 antagonist
14. Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioural studies
15. 3 antagonist trial
16. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors
17. 2 dopamine receptor blockade
18. Seroquel: biochemical profile of a potential atypical antipsychotic
19. Neurochemical and in vivo pharmacological profile of sertindole, a limbic-selective neuroleptic compound
20. 4
21. 2 receptor antagonist MDL 100,907 as a putative atypical antipsychotic: behavioural, electrophysiological and neurochemical studies
22. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies
23. 3-like receptors
24. 3 receptors in the cerebral cortex and superior cervical ganglion of the rat
25. Ondansetron for hallucinosis in advanced Parkinson's disease